08:58 AM EDT, 09/23/2025 (MT Newswires) -- Health care stocks were steady premarket Tuesday, with the Health Care Select Sector SPDR Fund (XLV) edging up 0.01% and the iShares Biotechnology ETF (IBB) inactive.

Scholar Rock Holding ( SRRK ) shares were down more than 12% after the company said the US Food and Drug Administration has issued a complete response letter for the marketing application of its spinal muscular atrophy drug, apitegromab, that cited issues at a third-party manufacturing site run by Catalent Indiana.